DOES THE A9285G POLYMORPHISM IN COLLAGEN TYPE XII α1 GENE ASSOCIATE WITH THE RISK OF ANTERIOR CRUCIATE LIGAMENT RUPTURES?
Ficek K, Stepien-Slodkowska M, Kaczmarczyk M, Maciejewska-Karlowska A, Sawczuk M, Cholewinski J, Leonska-Duniec A, Zarebska A, Cieszczyk P, Zmijewski P,
*Corresponding Author: Piotr Zmijewski, Ph.D., Institute of Sport, Department of Physiology, Trylogii 2/16, 01-982 Warsaw, Poland. Tel.: +48-228340812. Fax: +480228350977. E-mail: piotr.zmijewski@insp.waw.pl
page: 41

MATERIALS AND METHODS

Study Subjects. A total of 91 male football players (23 ± 3 years) with surgically diagnosed primary ACL ruptures who qualified for ligament reconstruction, were recruited for this study through Galen Orthopaedics, Bieruń, Poland. The control group comprised 143 apparently healthy, male football players (25 ± 2.6 years), of the same ethnicity, a similar age category, and a comparable level of exposure to ACL injury, who were without any selfreported history of ligament or tendon injury. Ethics Committee. The study was conducted in accordance with the ethical standards as described by Kruk [19]. Additionally, the Pomeranian Medical University (Szczecin, Poland) Ethics Committee approved the details of this study and all related informational and consent documentation before any data collection. In accordance with the Pomeranian Medical University Ethics Committee’s guidelines, the investigator informed all the subjects as to the benefits and possible risks associated with participation in the study, and all subjects signed a written informed consent document indicating their voluntary participation. Genotyping. Genomic DNA was extracted from the oral epithelial cells using GenElute Mammalian Genomic DNA Miniprep Kit (Sigma-Aldrich Chemie, Steinheim, Germany) according to manufacturer’s protocol. Allelic discrimination of the A9285G COL12A1 (rs970547) polymorphic site was performed using a TaqMan Pre-Designed SNP Genotyping Assays (Applied Biosystems, Foster City, CA, USA), including primers and fluorescently labelled (FAM and VIC) MGB probes for the detection of the alleles. All samples were genotyped on a Rotor-Gene real-time polymerase chain reaction (Re-Ti-PCR) instrument (Corbett Research, Sydney, NSW, Australia). Thermal cycler conditions were as follows: an initial step at 95 °C for 5 min., followed by 45 cycles of denaturation at 94 °C for 15 seconds and annealing/extension at 60 °C for 1 min. Statistical Analysis. Any differences in genotype and allele frequency were analyzed using χ2 tests (or Fisher exact tests). Odds ratios (OR) with 95% confidence intervals (95% CI) were calculated. All calculations were performed using Statistica (StatSoft Inc., Tulsa, OK, USA; 2011). STATISTICA (data analysis software system, version 10, www.statsoft.com) was used for computing statistics, except Hardy-Weinberg equilibrium which was tested with the programming language and environment R (http://www.r-project.org) and the test for linear trend, which was performed using the STATCALC module in Epi Info (http://wwwn.cdc.gov/ epiinfo). The p <0.05 values were considered to be statistically significant.



Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006